Adjuvant glycerol is not beneficial in experimental pneumococcal meningitis
Data(s) |
2010
|
---|---|
Resumo |
Bacterial meningitis in children causes high rates of mortality and morbidity. In a recent clinical trial, oral glycerol significantly reduced severe neurological sequelae in paediatric meningitis caused by Haemophilus influenzae type b, and a tendency towards a benefit of adjunctive glycerol was seen in pneumococcal meningitis. |
Formato |
application/pdf |
Identificador |
http://boris.unibe.ch/2685/1/1471-2334-10-84.pdf Blaser, Cornelia; Klein, Matthias; Grandgirard, Denis; Wittwer, Matthias; Peltola, Heikki; Weigand, Michael; Koedel, Uwe; Leib, Stephen L. (2010). Adjuvant glycerol is not beneficial in experimental pneumococcal meningitis. BMC infectious diseases, 10(84), p. 84. London: BioMed Central 10.1186/1471-2334-10-84 <http://dx.doi.org/10.1186/1471-2334-10-84> doi:10.7892/boris.2685 info:doi:10.1186/1471-2334-10-84 info:pmid:20353584 urn:issn:1471-2334 |
Idioma(s) |
eng |
Publicador |
BioMed Central |
Relação |
http://boris.unibe.ch/2685/ |
Direitos |
info:eu-repo/semantics/openAccess |
Fonte |
Blaser, Cornelia; Klein, Matthias; Grandgirard, Denis; Wittwer, Matthias; Peltola, Heikki; Weigand, Michael; Koedel, Uwe; Leib, Stephen L. (2010). Adjuvant glycerol is not beneficial in experimental pneumococcal meningitis. BMC infectious diseases, 10(84), p. 84. London: BioMed Central 10.1186/1471-2334-10-84 <http://dx.doi.org/10.1186/1471-2334-10-84> |
Tipo |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion PeerReviewed |